Mostrar el registro sencillo del ítem
dc.contributor.author
Linetzky, Bruno
dc.contributor.author
Curtis, Brad
dc.contributor.author
Frechtel, Gustavo Daniel
dc.contributor.author
Montenegro, Renan
dc.contributor.author
Escalante Pulido, Miguel
dc.contributor.author
Stempa, Oded
dc.contributor.author
De Lana, Janaina Martins
dc.contributor.author
Gagliardino, Juan Jose
dc.date.available
2019-03-25T00:58:04Z
dc.date.issued
2016-07
dc.identifier.citation
Linetzky, Bruno; Curtis, Brad; Frechtel, Gustavo Daniel; Montenegro, Renan; Escalante Pulido, Miguel; et al.; Challenges associated with insulin therapy progression among patients with type 2 diabetes: Latin American MOSAIc study baseline data; BioMed Central Ltd.; Diabetology and Metabolic Syndrome; 8; 1; 7-2016
dc.identifier.issn
1758-5996
dc.identifier.uri
http://hdl.handle.net/11336/72393
dc.description.abstract
Poor glycemic control in patients with type 2 diabetes is commonly recorded worldwide; Latin America (LA) is not an exception. Barriers to intensifying insulin therapy and which barriers are most likely to negatively impact outcomes are not completely known. The objective was to identify barriers to insulin progression in individuals with type 2 diabetes mellitus (T2DM) in LA countries (Mexico, Brazil, and Argentina).
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
BioMed Central Ltd.
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
Diabetes Education
dc.subject
Diabetes Knowledge
dc.subject
Diabetes Self-Care Management
dc.subject
Insulin Treatment
dc.subject
Latin America
dc.subject
Observational Study
dc.subject
Psychological Impact
dc.subject
Quality of Care
dc.subject
Type 2 Diabetes
dc.subject.classification
Endocrinología y Metabolismo
dc.subject.classification
Medicina Clínica
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
Challenges associated with insulin therapy progression among patients with type 2 diabetes: Latin American MOSAIc study baseline data
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2019-03-21T14:19:49Z
dc.journal.volume
8
dc.journal.number
1
dc.journal.pais
Reino Unido
dc.description.fil
Fil: Linetzky, Bruno. Ely Lilly Interamerica ; Argentina
dc.description.fil
Fil: Curtis, Brad. Eli Lilly and Company; Estados Unidos
dc.description.fil
Fil: Frechtel, Gustavo Daniel. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Inmunología, Genética y Metabolismo. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Inmunología, Genética y Metabolismo; Argentina. Hospital Sirio Libanés; Argentina
dc.description.fil
Fil: Montenegro, Renan. Universidade Estadual do Ceará; Brasil
dc.description.fil
Fil: Escalante Pulido, Miguel. Hospital de Especialidades del Centro Médico de Occidente IMSS; México
dc.description.fil
Fil: Stempa, Oded. Eli Lilly and Company Mexico; México
dc.description.fil
Fil: De Lana, Janaina Martins. Eli Lilly and Company Brasil; Brasil
dc.description.fil
Fil: Gagliardino, Juan Jose. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - la Plata. Centro de Endocrinología Experimental y Aplicada. Universidad Nacional de la Plata. Facultad de Ciencias Médicas. Centro de Endocrinología Experimental y Aplicada; Argentina
dc.journal.title
Diabetology and Metabolic Syndrome
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957288/
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1186/s13098-016-0157-1
Archivos asociados
Tamaño:
832.2Kb
Formato:
PDF